Risk stratification of cardiogenic cerebral embolism using serological parameters, and efficacy and safety of pharmacological and non-pharmacological treatment: retrospective study

Risk stratification of cardiogenic cerebral embolism using serological parameters, and efficacy and safety of pharmacological and non-pharmacological treatment: retrospective study - Risk stratification of cardiogenic cerebral embolism

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020635

Enrollment

400

Registered

2016-01-19

Start date

2016-01-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with atrial fibrillation

Exclusion criteria

Exclusion criteria: Patients with follow up period < 6 months

Design outcomes

Primary

Measure	Time frame
death, cerebral infarction, bleeding complication	—

Countries

Japan

Contacts

Public ContactKoji Miyamoto

National Cerebral and Cardiovascular Center Department of Cardiovascular Medicine

kojimiya@hsp.ncvc.go.jp06-6833-5012

Outcome results